Is There a Relevant Clinical Impact in Differentiating Idiopathic

Andrology Infertility Infertility etiology Testis abnormalities Vitamin D

Journal

The world journal of men's health
ISSN: 2287-4208
Titre abrégé: World J Mens Health
Pays: Korea (South)
ID NLM: 101596899

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 09 05 2022
accepted: 10 08 2022
pubmed: 15 9 2022
medline: 15 9 2022
entrez: 14 9 2022
Statut: ppublish

Résumé

Overall, male factor infertility (MFI) accounts for up to 50% of etiologies of couple's infertility, with almost 30% of MFI cases being idiopathic in nature. Idiopathic MFI does not support a tailored treatment work-up in clinical practice. To investigate rates of and characteristics of men presenting for idiopathic Demographic, clinical and laboratory data from 3,098 primary infertile men consecutively evaluated were analyzed and compared with those of 103 fertile controls. Idiopathic male infertility (IMI) was defined for abnormality at semen analysis with no previous history of diseases affecting fertility and normal findings on physical examination and genetic and laboratory testing. Unexplained male infertility (UMI) was defined as infertility of unknown origin with completely normal findings at semen analysis. Descriptive statistics and logistic regression models tested the association between clinical variables and idiopathic infertility status. Overall, 570 (18.5%) and 154 (5.0%) patients depicted criteria suggestive for either IMI or UMI, respectively. Groups were similar in terms of age, BMI, CCI, recreational habits, hormonal milieu, and sperm DNA fragmentation indexes. Conversely, testicular volume was lower in IMI (p<0.001). Vitamin D3 levels were lower in IMI Current findings further support the urgent need of a more detailed and comprehensive assessment of infertile men to better tailoring their management work-up in the everyday clinical setting.

Identifiants

pubmed: 36102103
pii: 40.e63
doi: 10.5534/wjmh.220069
pmc: PMC10042653
doi:

Types de publication

Journal Article

Langues

eng

Pagination

354-362

Informations de copyright

Copyright © 2023 Korean Society for Sexual Medicine and Andrology.

Déclaration de conflit d'intérêts

The authors have nothing to disclose.

Références

Andrologia. 2021 Feb;53(1):e13861
pubmed: 33125742
Andrology. 2017 May;5(3):505-510
pubmed: 28409903
Chronobiol Int. 2017;34(4):471-479
pubmed: 28306393
Int J Endocrinol. 2013;2013:145792
pubmed: 24089610
Hum Reprod Update. 2010 May-Jun;16(3):231-45
pubmed: 19934213
Gene. 2015 May 1;561(2):171-80
pubmed: 25682935
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Nat Rev Dis Primers. 2019 May 30;5(1):38
pubmed: 31147553
Front Endocrinol (Lausanne). 2021 Jan 19;11:591837
pubmed: 33542705
Acta Endocrinol (Buchar). 2017 Apr-Jun;13(2):180-187
pubmed: 31149171
World J Mens Health. 2019 Sep;37(3):296-312
pubmed: 31081299
Eur Urol. 2021 Nov;80(5):603-620
pubmed: 34511305
Int J Impot Res. 2021 Dec 1;:
pubmed: 34853436
Andrologia. 2021 Oct;53(9):e14172
pubmed: 34197002
Int Braz J Urol. 2012 Sep-Oct;38(5):576-94
pubmed: 23131516
J Urol. 2021 Jan;205(1):36-43
pubmed: 33295257
Hum Reprod. 2015 May;30(5):1110-21
pubmed: 25788568
Eur Urol. 2016 Dec;70(6):920-923
pubmed: 27343001
Lancet. 2021 Jan 23;397(10271):319-333
pubmed: 33308486
Andrologia. 2018 Apr;50(3):
pubmed: 29235139
Asian J Androl. 2021 Jan-Feb;23(1):52-58
pubmed: 32341213
N Engl J Med. 2021 Aug 19;385(8):707-719
pubmed: 34347949
Asian J Androl. 2021 Sep-Oct;23(5):501-509
pubmed: 33723100
Eur Urol. 2021 Feb;79(2):234-240
pubmed: 32814638
Fertil Steril. 2021 Oct;116(4):973-979
pubmed: 34289935
Nutrients. 2015 Dec 02;7(12):9972-84
pubmed: 26633484

Auteurs

Christian Corsini (C)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Luca Boeri (L)

Department of Urology, Foundation IRCCS Ca' Granda - Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Luigi Candela (L)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Edoardo Pozzi (E)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Federico Belladelli (F)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Paolo Capogrosso (P)

Department of Urology and Andrology, Ospedale di Circolo and Macchi Foundation, Varese, Italy.

Giuseppe Fallara (G)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Nicolò Schifano (N)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Daniele Cignoli (D)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Eugenio Ventimiglia (E)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Alessia D'Arma (A)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.

Massimo Alfano (M)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.

Francesco Montorsi (F)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy.

Andrea Salonia (A)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
University Vita-Salute San Raffaele, Milan, Italy. salonia.andrea@hsr.it.

Classifications MeSH